K012789

Substantially Equivalent

MODIFIED TO LDL/HDL CHOL DIRECT KIT-P.N. 4005, 4103,4123

Applicant: Morax
Product code: JHO
Advisory panel: Clinical Chemistry
Date received: 2001-08-20
Decision date: 2002-01-17
Decision: Substantially Equivalent
Clearance type: Special
Location: Chelsea, MI, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.